Topical β-blockers for treatment of glaucoma and the risk of Parkinson's disease.

چکیده

Reports have suggested that treatment with systemic β-adrenoceptor antagonists (β-blockers) may increase the risk of developing Parkinson's disease (PD). The objective of this study was to assess the association between the use of topical β-blockers and PD. A retrospective cohort study. All newly…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط

• لنز داخل چشمی
• گلوکوم (آب سیاه)